Mannheim, Germany

Max Berg

USPTO Granted Patents = 20 

 

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):

Title: The Innovative Contributions of Max Berg in Analyte Detection

Introduction

Max Berg, an accomplished inventor based in Mannheim, Germany, has made significant contributions to the field of medical technology, particularly in analyte detection methods. With a total of 12 patents to his name, Berg's innovative spirit and dedication to improving healthcare through technology are evident in his latest inventions.

Latest Patents

Among his recent patents is a groundbreaking method for determining the concentration of an analyte in a bodily fluid. This method leverages a mobile device equipped with a camera, guiding users to apply their body fluid to an optical test strip. After a predetermined waiting time, the device captures an image of the test field, enabling the accurate determination of analyte concentration by analyzing specific color channels. Additionally, he has developed a detection method that utilizes a mobile device with a camera and illumination source to detect analytes in samples. This method involves comparing multiple images captured before and after applying the sample, providing precise results based on differences in light intensities.

Career Highlights

Max Berg is currently affiliated with Roche Diabetes Care, Inc., where he works as part of a team dedicated to advancing diabetes care through innovative technologies. Throughout his career, Berg has focused on creating solutions that enhance the accuracy and efficiency of medical testing, reflecting his commitment to improving patient outcomes.

Collaborations

Berg collaborates with notable colleagues such as Bernd Limburg and Fredrik Hailer, contributing to a dynamic environment that fosters innovation. Their collective expertise in research and development within Roche Diabetes Care, Inc. drives the creation of cutting-edge solutions in the diabetes care sector.

Conclusion

Max Berg's contributions to the field of analyte detection exemplify the impact of innovation on healthcare, paving the way for advancements that benefit patients and healthcare providers alike. His dedication to enhancing medical technology continues to inspire future developments in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…